Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

PODD
Insulet Corporation
stock NASDAQ

At Close
Jul 11, 2025 3:59:53 PM EDT
289.33USD-2.714%(-8.07)507,506
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 9, 2025 8:00:30 AM EDT
302.16USD+1.601%(+4.76)0
After-hours
Jul 11, 2025 4:00:30 PM EDT
289.32USD-0.003%(-0.01)3,247
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
10:29AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022   Benzinga
10:27AM EST  Expert Ratings For Insulet   Benzinga
09:15AM EST  Oppenheimer Upgrades Insulet to Outperform, Lowers Price Target to $275   Benzinga
Jan 28, 2022
12:11PM EST  Mid-Day Market Update: US Stocks Turn Positive; Nasdaq Surges 2%   Benzinga
08:54AM EST  Benzinga Pro's Top 5 Stocks To Watch For Friday, Jan. 28, 2022: PODD, KR, TEAM, GOOGL, SBUX   Benzinga
06:51AM EST  Insulet Corporation (PODD), a medical devices company, said on Friday that it has received clearance from the FDA for its Omnipod 5 automated insulin delivery system or Omnipod 5, for the type one diabetes patients aged six years or above.   RTTNews
06:15AM EST  Insulet Announced FDA Clearance of its Omnipod 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control   Benzinga
06:12AM EST  Insulet Gets FDA Clearance For Omnipod 5 For Individuals Aged Six Years And Older With Type 1 Diabetes   RTTNews
06:00AM EST  Insulet Announces FDA Clearance of its Omnipod(r) 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control   Business Wire
Jan 13, 2022
11:52AM EST  If You Invested $100 In This Stock 5 Years Ago, Here's How Much You Would Have Today   Benzinga
Jan 12, 2022
10:16AM EST  CORRECTING and REPLACING Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022   Business Wire
06:00AM EST  Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2021   Business Wire
Jan 7, 2022
01:07PM EST  Morgan Stanley Maintains Equal-Weight on Insulet, Lowers Price Target to $300   Benzinga
Dec 20, 2021
08:32AM EST  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the appointment of Jessica Hopfield, Ph.D. to the Berkeley Lights Board of Directors as an independent director, effective December 15, 2021.   GlobeNewswire Inc
Nov 24, 2021
06:00AM EST  Insulet to Present at Nasdaq's 45th Investor Conference   Business Wire
Nov 8, 2021
07:24AM EST  10 Biggest Price Target Changes For Monday   Benzinga
04:07AM EST  Raymond James Maintains Outperform on Insulet, Raises Price Target to $329   Benzinga
Nov 5, 2021
10:36AM EDT  Morgan Stanley Maintains Equal-Weight on Insulet, Raises Price Target to $303   Benzinga
10:05AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
09:38AM EDT  SVB Leerink Maintains Outperform on Insulet, Raises Price Target to $350   Benzinga
09:22AM EDT  Insulet Expects Q4 Sales Growth Of 19-25%, Raises FY21 Sales Growth Expectations From 16-20% To 18-20%   Benzinga
09:22AM EDT  Insulet Q3 EPS $0.18 Misses $0.24 Estimate, Sales $275.60M Beat $273.18M Estimate   Benzinga
Nov 4, 2021
04:01PM EDT  Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year   Business Wire
08:19AM EDT  The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO   Benzinga
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Nov 1, 2021
06:00AM EDT  Insulet Honors Diabetes Awareness with Global Activities and Events   Business Wire
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 18, 2021
06:06AM EDT  Insulet Appoints Luciana Borio To Board   RTTNews
06:00AM EDT  Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford   Business Wire
Sep 30, 2021
01:47PM EDT  Insulet's Insulin Delivery System Shows Durable Glycemic Control With One Year of Use   Benzinga
07:53AM EDT  Insulet Corp. (PODD) said that Omnipod 5 Automated Insulin Delivery System, the world's first tubeless, wearable system that continuously adapts insulin delivery based on glucose levels and trends, significantly improved time in range and reduced HbA1c in children, adolescents, and adults, aged 6-70 years, with type 1 diabetes over a period of 12 months.   RTTNews
07:35AM EDT  Insulet's Omnipod 5 Study Extension Data Shows Significant Improvements In Glycemic Control With One Year Of Use   RTTNews
07:34AM EDT  Insulet Corporation Announces Co.'s Omnipod 5 Pivotal Study Extension Data Shows Significant Improvements In Glycemic Control With One Year Of Use   Benzinga
07:30AM EDT  Insulet's Omnipod(r) 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use   Business Wire
Sep 29, 2021
04:01PM EDT  Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021   Business Wire
Sep 9, 2021
08:17AM EDT  The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization   Benzinga
Sep 8, 2021
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
Aug 26, 2021
04:01PM EDT  Insulet to Present at Upcoming Investor Conferences   Business Wire
Aug 23, 2021
11:39AM EDT  Looking into Insulet's Return on Capital Employed   Benzinga
Aug 16, 2021
03:01PM EDT  FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps   Benzinga
07:36AM EDT  Insulet Says FDA Clears Lilly's Lyumjev Rapid-Acting Insulin For Use With Omnipod Products In U.S.   RTTNews
07:31AM EDT  Insulet Announces FDA Clearance of Lyumjev Rapid-Acting Insulin for Use with Omnipod Products in the United States   Benzinga
07:30AM EDT  Insulet Announces FDA Clearance of Lyumjev(r) Rapid-Acting Insulin for Use with Omnipod(r) Products in the United States   Business Wire
Aug 11, 2021
04:01PM EDT  Insulet Introduces Omnipod DASH(r) System at Australasian Diabetes Congress   Business Wire
Aug 6, 2021
07:54AM EDT  Insulet Q2 GAAP EPS $(0.37), Adj. EPS $0.23, Sales $263.20M Beat $259.19M Estimate   Benzinga
07:53AM EDT  UPDATE: Insulet Q2 Adj. EPS $0.23   Benzinga
05:40AM EDT  SVB Leerink Maintains Outperform on Insulet, Lowers Price Target to $300   Benzinga
Aug 5, 2021
04:36PM EDT  Insulet Expects Q3 Sales Growth Of 11-18%, Reaffirms FY21 Sales Growth Expectations Of 16-20%   Benzinga
04:35PM EDT  Insulet Q2 EPS $(0.37) Down From $0.22 YoY, Sales $263.20M Beat $259.19M Estimate   Benzinga
04:01PM EDT  Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year   Business Wire
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Jul 26, 2021
06:00AM EDT  Insulet to Present at Upcoming Investor Conferences   Business Wire
Jul 20, 2021
12:14PM EDT  SVB Leerink Maintains Outperform on Insulet, Raises Price Target to $325   Benzinga
Jul 1, 2021
06:00AM EDT  Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021   Business Wire
Jun 28, 2021
09:59AM EDT  Insulet Late Saturday Reported Co.'s Omnipod 5 Automated Insulin Delivery System Pivotal Studies Showed Improved Outcomes Across Lifespan From Ages 2-70 Years   Benzinga
Jun 26, 2021
04:00PM EDT  Insulet's Omnipod(r) 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years   Business Wire
Jun 24, 2021
06:06AM EDT  Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod 5 System   Benzinga
May 25, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021   Benzinga
06:42AM EDT  Barclays Initiates Coverage On Insulet with Overweight Rating, Announces Price Target of $300   Benzinga
May 7, 2021
08:20AM EDT  Raymond James Maintains Outperform on Insulet, Lowers Price Target to $285   Benzinga
07:38AM EDT  SVB Leerink Maintains Outperform on Insulet, Lowers Price Target to $300   Benzinga
May 6, 2021
04:18PM EDT  Insulet Expects Q2 Sales Growth of 10-14%, Raises Low End Of FY21 Sales Expectations From 15%-20% to 16%-20%   Benzinga
04:17PM EDT  Insulet Q1 Sales $252.30M Beat $247.16M Estimate   Benzinga
04:01PM EDT  Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year   Business Wire
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
May 4, 2021
06:00AM EDT  Insulet to Present at BofA Securities 2021 Virtual Healthcare Conference   Business Wire
May 3, 2021
06:00AM EDT  Insulet 2020 Sustainability Report Conveys Strategy to Deliver Growth with Purpose   Business Wire
Apr 30, 2021
07:31AM EDT  The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs   Benzinga
Apr 29, 2021
04:01PM EDT  Insulet Announces Pricing of New Senior Secured Credit Facilities   Business Wire
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
Apr 28, 2021
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
Apr 27, 2021
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
Apr 19, 2021
07:56AM EDT  Insulet Announces Launch of Syndication of New Credit Facilities   Business Wire
Apr 5, 2021
06:00AM EDT  Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021   Business Wire
Apr 1, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2021   Benzinga
08:42AM EDT  10 Biggest Price Target Changes For Thursday   Benzinga
06:33AM EDT  SVB Leerink Upgrades Insulet to Outperform, Raises Price Target to $320   Benzinga
Mar 20, 2021
11:54AM EDT  Insulet Announces Positive Results From First Pivotal Trial For Omnipod(r) 5 Automated Insulin Delivery System   RTTNews
11:45AM EDT  Insulet's Omnipod(r) 5 Automated Insulin Delivery System Improves Clinical Outcomes in Type 1 Diabetes   Business Wire
Mar 19, 2021
11:26AM EDT  Canaccord Genuity Upgrades Insulet to Buy, Announces $280 Price Target   Benzinga
Mar 16, 2021
04:01PM EDT  Insulet to Host an Investor Webcast to Discuss Omnipod(r) 5 Pivotal Data   Business Wire
Feb 25, 2021
11:47AM EST  Oppenheimer Maintains Perform on Insulet, Raises Price Target to $277   Benzinga
Feb 24, 2021
11:39AM EST  Raymond James Maintains Outperform on Insulet, Raises Price Target to $296   Benzinga
09:36AM EST  SVB Leerink Maintains Market Perform on Insulet, Raises Price Target to $275   Benzinga
Feb 23, 2021
04:45PM EST  Recap: Insulet Q4 Earnings   Benzinga
04:07PM EST  Insulet Expects Q1 Sales Growth of 20%-24%, FY21 Sales Growth of 15%-20%   Benzinga
04:06PM EST  Insulet Q4 EPS $(0.26) Misses $(0.04) Estimate, Sales $246.10M Beat $232.89M Estimate   Benzinga
04:01PM EST  Insulet Reports Full Year 2020 Revenue Increase of 23% and Fourth Quarter 2020 Revenue Increase of 18% Year-Over-Year   Business Wire
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
04:09AM EST  Earnings Scheduled For February 23, 2021   Benzinga
Feb 8, 2021
04:01PM EST  Insulet to Present at Upcoming Investor Conferences   Business Wire
Jan 29, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021   Benzinga
06:11AM EST  Piper Sandler Downgrades Insulet to Neutral   Benzinga
Jan 21, 2021
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 18, 2021
06:21AM EST  Insulet Launches Easy-to-use Insulin Delivery System In   RTTNews
06:07AM EST  Insulet Unveils Omnipod DASH Insulin Management System In Canada   RTTNews
06:01AM EST  Insulet's Omnipod DASH(r) System Now Available in Canada   Business Wire
Jan 15, 2021
07:57AM EST  The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges   Benzinga
Jan 14, 2021
07:57AM EST  The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates   Benzinga
Jan 11, 2021
06:00AM EST  Insulet to Announce Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021   Business Wire
Dec 28, 2020
04:08PM EST  Insulet Announces Has Settled Dispute With Former Exclusive European Distributor Ypsomed AG; Has Agreed To Pay Ypsomed An Additional One-Time Payment Of $36.15M, For A Total Expiration Fee Of $41.25M   Benzinga
Dec 21, 2020
06:00AM EST  Insulet to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference   Business Wire
Dec 16, 2020
11:25AM EST  Benzinga's Top Upgrades, Downgrades For December 16, 2020   Benzinga
09:42AM EST  Citigroup Downgrades Insulet to Neutral   Benzinga
Dec 15, 2020
12:17PM EST  Morgan Stanley Maintains Equal-Weight on Insulet, Raises Price Target to $276   Benzinga
Nov 13, 2020
07:40AM EST  The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations   Benzinga
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 9, 2020
04:01PM EST  Insulet to Present at Upcoming Investor Conferences   Business Wire
Nov 6, 2020
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
Nov 5, 2020
12:17PM EST  Canaccord Genuity Maintains Hold on Insulet, Raises Price Target to $240   Benzinga
11:09AM EST  UBS Maintains Neutral on Insulet, Raises Price Target to $245   Benzinga
09:09AM EST  Raymond James Maintains Outperform on Insulet, Raises Price Target to $250   Benzinga
08:16AM EST  Morgan Stanley Maintains Equal-Weight on Insulet, Raises Price Target to $246   Benzinga
Nov 4, 2020
04:16PM EST  Insulet Raises FY20 Sales Growth Guidance From 17%-19% To 20%-21%; Sees Q4 Sales Growth Of 7%-11%   Benzinga
04:15PM EST  Insulet Q3 EPS $0.17 Beats $0.08 Estimate, Sales $234.00M Beat $221.68M Estimate   Benzinga
04:01PM EST  Insulet Reports Third Quarter 2020 Revenue Increase of 22% Year-Over-Year   Business Wire
10:09AM EST  Stocks Trading Near 52-Week Highs Just After Open On Wednesday, Nov. 4, 2020 Include NICE, ETN, CDNS, CARR, HUM, ANTM, Others   Benzinga
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
04:41AM EST  Earnings Scheduled For November 4, 2020   Benzinga
Nov 2, 2020
06:01AM EST  Insulet Raises Awareness for Diabetes Throughout November   Business Wire
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
06:00AM EDT  Insulet Recognized as Global Impact Corporate Hero and Manufacturer of the Year   Business Wire
Oct 20, 2020
04:10PM EDT  Insulet Appoints Wayne Frederick To Board Of Directors   RTTNews
04:01PM EDT  Insulet Appoints Wayne A. I. Frederick, M.D., to Board of Directors   Business Wire
Oct 12, 2020
10:23AM EDT  SVB Leerink Maintains Market Perform on Insulet, Raises Price Target to $255   Benzinga
Oct 5, 2020
06:00AM EDT  Insulet to Announce Third Quarter 2020 Financial Results on November 4, 2020   Business Wire
Sep 21, 2020
06:09AM EDT  Insulet Commercially Launchess Omnipod DASH(r) Insulin Management System In Additional Countries   RTTNews
06:01AM EDT  Insulet Expands its Offering of Omnipod DASH(r) Insulin Management System   Business Wire
Aug 24, 2020
06:00AM EDT  Insulet to Present at Upcoming Investor Conferences   Business Wire
Aug 7, 2020
02:10PM EDT  Insulet shares are trading higher after the company reported Q2 EPS results up from last year and better-than-expected sales results. UPDATE: Shares have reversed since then.   Benzinga
09:52AM EDT  Morgan Stanley Maintains Equal-Weight on Insulet, Raises Price Target to $232   Benzinga
07:57AM EDT  Raymond James Maintains Outperform on Insulet, Raises Price Target to $249   Benzinga
07:22AM EDT  SVB Leerink Maintains Market Perform on Insulet, Raises Price Target to $240   Benzinga
Aug 6, 2020
04:19PM EDT  Insulet Raises FY20 Revenue Growth From 15% to 17%-19%   Benzinga
04:18PM EDT  Insulet Q2 EPS $0.22 Up From $0.02 YoY, Sales $226.30M Beat $212.41M Estimate   Benzinga
04:01PM EDT  Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year   Business Wire
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
Jul 28, 2020
09:37AM EDT  Benzinga's Top Upgrades, Downgrades For July 28, 2020   Benzinga
06:24AM EDT  Wells Fargo Initiates Coverage On Insulet with Overweight Rating, Announces Price Target of $231   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC